 Pharmacokinetics famotidine intravenous administration liver disease pharmacokinetics famotidine administration single intravenous dose normal volunteers patients chronic hepatitis patients compensated cirrhosis patients decompensated cirrhosis plasma terminal elimination half-life famotidine famotidine total body clearance patients decompensated cirrhosis creatinine clearance changes significant patients chronic hepatitis creatinine clearance patients compensated cirrhosis creatinine clearance comparison normal volunteers total volume distribution steady state different normal volunteers groups patients Famotidine total body clearance weak significant correlation creatinine clearance serum albumin level serum total bilirubin level reduction clearance due part concomitant renal impairment hepatic dysfunction patients conclusion famotidine total body clearance decompensated cirrhosis dose schedule modification patients condition